Cargando…

Mortality Associated with Neurofibromatosis 1: A Cohort Study of 1895 Patients in 1980-2006 in France

BACKGROUND: Neurofibromatosis 1 (NF1), a common autosomal dominant disorder, was shown in one study to be associated with a 15-year decrease in life expectancy. However, data on mortality in NF1 are limited. Our aim was to evaluate mortality in a large retrospective cohort of NF1 patients seen in Fr...

Descripción completa

Detalles Bibliográficos
Autores principales: Duong, Tu Anh, Sbidian, Emilie, Valeyrie-Allanore, Laurence, Vialette, Cédric, Ferkal, Salah, Hadj-Rabia, Smaïl, Glorion, Christophe, Lyonnet, Stanislas, Zerah, Michel, Kemlin, Isabelle, Rodriguez, Diana, Bastuji-Garin, Sylvie, Wolkenstein, Pierre
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3095535/
https://www.ncbi.nlm.nih.gov/pubmed/21542925
http://dx.doi.org/10.1186/1750-1172-6-18
_version_ 1782203658787618816
author Duong, Tu Anh
Sbidian, Emilie
Valeyrie-Allanore, Laurence
Vialette, Cédric
Ferkal, Salah
Hadj-Rabia, Smaïl
Glorion, Christophe
Lyonnet, Stanislas
Zerah, Michel
Kemlin, Isabelle
Rodriguez, Diana
Bastuji-Garin, Sylvie
Wolkenstein, Pierre
author_facet Duong, Tu Anh
Sbidian, Emilie
Valeyrie-Allanore, Laurence
Vialette, Cédric
Ferkal, Salah
Hadj-Rabia, Smaïl
Glorion, Christophe
Lyonnet, Stanislas
Zerah, Michel
Kemlin, Isabelle
Rodriguez, Diana
Bastuji-Garin, Sylvie
Wolkenstein, Pierre
author_sort Duong, Tu Anh
collection PubMed
description BACKGROUND: Neurofibromatosis 1 (NF1), a common autosomal dominant disorder, was shown in one study to be associated with a 15-year decrease in life expectancy. However, data on mortality in NF1 are limited. Our aim was to evaluate mortality in a large retrospective cohort of NF1 patients seen in France between 1980 and 2006. METHODS: Consecutive NF1 patients referred to the National French Referral Center for Neurofibromatoses were included. The standardized mortality ratio (SMR) with its 95% confidence interval (CI) was calculated as the ratio of observed over expected numbers of deaths. We studied factors associated with death and causes of death. RESULTS: Between 1980 and 2006, 1895 NF1 patients were seen. Median follow-up was 6.8 years (range, 0.4-20.6). Vital status was available for 1226 (65%) patients, of whom 1159 (94.5%) survived and 67 (5.5%) died. Overall mortality was significantly increased in the NF1 cohort (SMR, 2.02; CI, 1.6-2.6; P < 10(-4)). The excess mortality occurred among patients aged 10 to 20 years (SMR, 5.2; CI, 2.6-9.3; P < 10(-4)) and 20 to 40 years (SMR, 4.1; 2.8-5.8; P < 10(-4)). Significant excess mortality was found in both males and females. In the 10-20 year age group, females had a significant increase in mortality compared to males (SMR, 12.6; CI, 5.7-23.9; and SMR, 1.8; CI, 0.2-6.4; respectively). The cause of death was available for 58 (86.6%) patients; malignant nerve sheath tumor was the main cause of death (60%). CONCLUSIONS: We found significantly increased SMRs indicating excess mortality in NF1 patients compared to the general population. The definitive diagnosis of NF1 in all patients is a strength of our study, and the high rate of death related to malignant transformation is consistent with previous work. The retrospective design and hospital-based recruitment are limitations of our study. Mortality was significantly increased in NF1 patients aged 10 to 40 years and tended to be higher in females than in males.
format Text
id pubmed-3095535
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-30955352011-05-17 Mortality Associated with Neurofibromatosis 1: A Cohort Study of 1895 Patients in 1980-2006 in France Duong, Tu Anh Sbidian, Emilie Valeyrie-Allanore, Laurence Vialette, Cédric Ferkal, Salah Hadj-Rabia, Smaïl Glorion, Christophe Lyonnet, Stanislas Zerah, Michel Kemlin, Isabelle Rodriguez, Diana Bastuji-Garin, Sylvie Wolkenstein, Pierre Orphanet J Rare Dis Research BACKGROUND: Neurofibromatosis 1 (NF1), a common autosomal dominant disorder, was shown in one study to be associated with a 15-year decrease in life expectancy. However, data on mortality in NF1 are limited. Our aim was to evaluate mortality in a large retrospective cohort of NF1 patients seen in France between 1980 and 2006. METHODS: Consecutive NF1 patients referred to the National French Referral Center for Neurofibromatoses were included. The standardized mortality ratio (SMR) with its 95% confidence interval (CI) was calculated as the ratio of observed over expected numbers of deaths. We studied factors associated with death and causes of death. RESULTS: Between 1980 and 2006, 1895 NF1 patients were seen. Median follow-up was 6.8 years (range, 0.4-20.6). Vital status was available for 1226 (65%) patients, of whom 1159 (94.5%) survived and 67 (5.5%) died. Overall mortality was significantly increased in the NF1 cohort (SMR, 2.02; CI, 1.6-2.6; P < 10(-4)). The excess mortality occurred among patients aged 10 to 20 years (SMR, 5.2; CI, 2.6-9.3; P < 10(-4)) and 20 to 40 years (SMR, 4.1; 2.8-5.8; P < 10(-4)). Significant excess mortality was found in both males and females. In the 10-20 year age group, females had a significant increase in mortality compared to males (SMR, 12.6; CI, 5.7-23.9; and SMR, 1.8; CI, 0.2-6.4; respectively). The cause of death was available for 58 (86.6%) patients; malignant nerve sheath tumor was the main cause of death (60%). CONCLUSIONS: We found significantly increased SMRs indicating excess mortality in NF1 patients compared to the general population. The definitive diagnosis of NF1 in all patients is a strength of our study, and the high rate of death related to malignant transformation is consistent with previous work. The retrospective design and hospital-based recruitment are limitations of our study. Mortality was significantly increased in NF1 patients aged 10 to 40 years and tended to be higher in females than in males. BioMed Central 2011-05-04 /pmc/articles/PMC3095535/ /pubmed/21542925 http://dx.doi.org/10.1186/1750-1172-6-18 Text en Copyright ©2011 Duong et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Duong, Tu Anh
Sbidian, Emilie
Valeyrie-Allanore, Laurence
Vialette, Cédric
Ferkal, Salah
Hadj-Rabia, Smaïl
Glorion, Christophe
Lyonnet, Stanislas
Zerah, Michel
Kemlin, Isabelle
Rodriguez, Diana
Bastuji-Garin, Sylvie
Wolkenstein, Pierre
Mortality Associated with Neurofibromatosis 1: A Cohort Study of 1895 Patients in 1980-2006 in France
title Mortality Associated with Neurofibromatosis 1: A Cohort Study of 1895 Patients in 1980-2006 in France
title_full Mortality Associated with Neurofibromatosis 1: A Cohort Study of 1895 Patients in 1980-2006 in France
title_fullStr Mortality Associated with Neurofibromatosis 1: A Cohort Study of 1895 Patients in 1980-2006 in France
title_full_unstemmed Mortality Associated with Neurofibromatosis 1: A Cohort Study of 1895 Patients in 1980-2006 in France
title_short Mortality Associated with Neurofibromatosis 1: A Cohort Study of 1895 Patients in 1980-2006 in France
title_sort mortality associated with neurofibromatosis 1: a cohort study of 1895 patients in 1980-2006 in france
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3095535/
https://www.ncbi.nlm.nih.gov/pubmed/21542925
http://dx.doi.org/10.1186/1750-1172-6-18
work_keys_str_mv AT duongtuanh mortalityassociatedwithneurofibromatosis1acohortstudyof1895patientsin19802006infrance
AT sbidianemilie mortalityassociatedwithneurofibromatosis1acohortstudyof1895patientsin19802006infrance
AT valeyrieallanorelaurence mortalityassociatedwithneurofibromatosis1acohortstudyof1895patientsin19802006infrance
AT vialettecedric mortalityassociatedwithneurofibromatosis1acohortstudyof1895patientsin19802006infrance
AT ferkalsalah mortalityassociatedwithneurofibromatosis1acohortstudyof1895patientsin19802006infrance
AT hadjrabiasmail mortalityassociatedwithneurofibromatosis1acohortstudyof1895patientsin19802006infrance
AT glorionchristophe mortalityassociatedwithneurofibromatosis1acohortstudyof1895patientsin19802006infrance
AT lyonnetstanislas mortalityassociatedwithneurofibromatosis1acohortstudyof1895patientsin19802006infrance
AT zerahmichel mortalityassociatedwithneurofibromatosis1acohortstudyof1895patientsin19802006infrance
AT kemlinisabelle mortalityassociatedwithneurofibromatosis1acohortstudyof1895patientsin19802006infrance
AT rodriguezdiana mortalityassociatedwithneurofibromatosis1acohortstudyof1895patientsin19802006infrance
AT bastujigarinsylvie mortalityassociatedwithneurofibromatosis1acohortstudyof1895patientsin19802006infrance
AT wolkensteinpierre mortalityassociatedwithneurofibromatosis1acohortstudyof1895patientsin19802006infrance